Hikal Limited

HIKAL Stock View

(NSE)

322.35

3,974.60
Proj. ROE (%)
11.90
Proj. P/E (x)
38.15
Proj EV / EBITDA (x)
13.54
Proj. P/BV (x)
3.11
Proj. Revenue ( Cr.)
2,000.05

Stock View

BUY
Share on
The average score for Hikal Limited stands at 3 against 2, three months back.

Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma, ingredients, and contract research activities. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). It offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
253.74
100 DMA ()
324.96
200 DMA ()
396.05
52 Weeks Range
212.00
742.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity